Combination systemic therapies in psoriatic arthritis

Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond

(2016) Praveen Rao et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

An update on methotrexate

(2010) Juergen Braun et al.   CURRENT OPINION IN RHEUMATOLOGY

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

(2009) Arthur Kavanaugh et al.   ARTHRITIS AND RHEUMATISM

Psoriatic arthritis assessment and treatment update

(2009) Philip J Mease   CURRENT OPINION IN RHEUMATOLOGY

Psoriatic arthritis

(2009) Dafna D. Gladman   Dermatologic Therapy

Time Trends in Epidemiology and Characteristics of Psoriatic Arthritis Over 3 Decades: A Population-based Study

(2009) F. C. WILSON et al.   JOURNAL OF RHEUMATOLOGY

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

(2009) Alice Gottlieb et al.   LANCET

Psoriatic arthritis: from pathogenesis to therapy

(2009) Oliver FitzGerald et al.   ARTHRITIS RESEARCH & THERAPY

Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis

(2008) A Spadaro et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment recommendations for psoriatic arthritis

(2008) C T Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES

Alefacept with methotrexate for treatment of psoriatic arthritis: Open-label extension of a randomized, double-blind, placebo-controlled study

(2008) Philip J. Mease et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY